JavaScript seem to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.
Research Grade Mavrilimumab is a human monoclonal antibody which targets Granulocyte-macrophage colony-stimulating factor receptor subunit alpha.